Litcius/Paper detail

LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer

Ajinkya A. Shitole, Neeti Sharma, Prabhanjan Giram, Anand P. Khandwekar, Meghna M. Baruah, Baijayantimala Garnaik, Santosh Koratkar

2020Materials Science and Engineering C67 citationsDOI

Topics & Concepts

In vivoPolyethylene glycolDocetaxelPharmacologyMaterials scienceCytotoxicityNanocapsulesLNCaPDrug deliveryPEG ratioHeLaIn vitroPaclitaxelViability assayCancer cellCancer researchChemistryCancerMedicineBiochemistryNanotechnologyBiologyInternal medicineNanoparticleEconomicsFinanceBiotechnologyNanoparticle-Based Drug DeliveryNuclear Structure and FunctionProstate Cancer Treatment and Research
LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer | Litcius